Photodynamic Therapy of Malignant Brain Tumours: A phase III trial

References

• Dougherty T J, Weishaupt K R, Boyle D G. Photosensi-tizers. Principles and Practice of Oncology, V T De Vita, Jr, S Hellman, S A Rosenburg. JB Lippincott, Philadelphia 1985; 2272–9
   Google Scholar
• Kessel D. Proposed structure of the tumor-localizing fraction of HPD. Photochem Photobiol 1986; 44: 193–6
   PubMed Web of Science ®Google Scholar
• Kaye A H, Morstyn G, Ashcroft R G. Uptake and retention of Hematoporyphrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 1985; 17: 883–90
   PubMed Web of Science ®Google Scholar
• Raab O. Uber die Wirkung fluoreszierender Stoffe auf Infusorien. Zeit Biol 1900; 39: 524
   Google Scholar
• Tappeiner H, Jesionek A. Therapeutische Versuche mit fluoreszierenden Stoffen. Munch Medizin Woch-enshr 1903; 1: 2042–4
   Google Scholar
• Policard A. Etudes sur les aspects offerts par des tumeurs experimentales examinee a la lumiere de woods. CR Soc Biol 1924; 91: 1423
   Google Scholar
• Auler H, Banzer G. Untersuchungen uber die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Zeit Krebs 1942; 53: 65
   Google Scholar
• Figge F HJ, Weiland G S, Manganiello L OJ. Cancer detection and therapy: affinity of neoplastic embryonic and traumatized regenerating tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 1948; 68: 640–1
   PubMed Web of Science ®Google Scholar
• Lipson R L, Baldes E J, Olsen A M. The use of a derivative of hematoporphyrin in tumour detection. J Nat Cancer Inst 1961; 26: 1–10
   PubMed Web of Science ®Google Scholar
• Schwartz S, Absolon K, Vermund H. Some relationship of porphyrins, x-rays and tumors. Bull Univ Minnesota Med Sch 1955; 27: 7–13
   Google Scholar
• Diamond I, McDonagh A F, Eilson C B, Granelli S G, Nielsen S, Jaenicke R. Photodynamic therapy of malignant tumours. Lancet 1972; 2: 1175–7
   PubMed Web of Science ®Google Scholar
• Dougherty T J, Kaufman J E, Goldfarb A, Weishaupt K R, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978; 38: 2628–35
   PubMed Web of Science ®Google Scholar
• Weishaupt K R, Gomer C J, Dougherty T J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976; 36: 2326–9
   PubMed Web of Science ®Google Scholar
• See K L, Forbes I J, Betts W H. Oxygen dependency of phototoxicity with ematoporphyrinderivative. Photochem Photobiol 1984; 39: 631–4
   PubMed Web of Science ®Google Scholar
• Bonnett R, Lambert C, Land E J, Scourides P A, Sinclair R S, Truscott T G. The triplet and radical species of hematoporphyrin and some of its derivatives. Photochem Photobiol 1983; 38(I)1–8
   PubMed Web of Science ®Google Scholar
• Grossweiner L I, Patel A S, Grossweiner J B. Type I and Type II mechanisms in the photosensitized lysis of phosphatidylcholine liposomes by hepatoporphyrin. Photochem Photobiol 1982; 36: 159–67
   PubMed Web of Science ®Google Scholar
• Swartz M R, Schnipper L W, Lewin A A, Crumpacker C S. Inactivation of herpes simplex virus with methylene blue, light and electricity. Proc Soc Exp Biol Med 1979; 161: 204–9
   PubMed Web of Science ®Google Scholar
• Kostron H, Swartz M R, Miller D C, Martuza R L. The interaction of hematoporphyrin derivative, light and ionizing radiation in a rat glioma model. Cancer 1986; 57: 964–70
   PubMed Web of Science ®Google Scholar
• Buettner G R, Oberley L W. The apparent production of superoxide and hydroxyl radicals by hematoporphyrin and light as seen by spintrapping. FEBS Lett 1980; 121: 161–4
   PubMed Web of Science ®Google Scholar
• Hariharan P V, Courtney J, Eleczko S. Production of hydroxyl radicals in cell systems exposed to hematoporphyrin and red light. Int J Radiation Biol 1980; 37: 691–4
   Web of Science ®Google Scholar
• Evensen J F, Sommer S, Moan J, Christensen T. Tumorlocalizing and photosensitizing properties of the main components of hematoporphyrin derivative. Cancer Res 1984; 44: 482–6
   PubMed Web of Science ®Google Scholar
• Kessel D. Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy. Photochem Photobiol 1984; 39(6)851–9
   PubMed Web of Science ®Google Scholar
• Kostron H, Weiser G, Fritsch E, Grunert V. Photodynamic treatment of malignant brain tumors: clinical and neuropathological results. Photochem Photobiol 1987; 46: 937–45
   PubMed Web of Science ®Google Scholar
• Muller P S, Wilson B C. Photodynamic therapy: cavitary photoillumination of malignant brain tumors using a laser coupled inflatable balloon. Can J Neurol Sci 1985; 12: 371–3
   PubMed Web of Science ®Google Scholar
• Laws E R, Wharen R E, Jr, Anderson R E. Photodynamic therapy of braintumors. Photodynamic therapy of tumors and other diseases, G Gori, C Perria. Liberia Progetto, Padova 1985; 311–6
   Google Scholar
• Forbes I J. Photochemotherapy of human cancers with hematoporphyrin derivative. Med J Australia 1984; 94–6
   PubMed Web of Science ®Google Scholar
• Hayata Y, Kato H, Okitsu H, Kawaguchi M, Konaka Ch. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. Sem Surg Oncol 1985; 1: 1–11
   PubMedGoogle Scholar
• Perria C. Photodynamic therapy of human gliomas by hematoporphyrin and He-Ne laser. IRCS Med Sci Cancer 1981; 9: 7–58
   Google Scholar
• Laws E R, Jr, Cortese D A, Kinsey J H. Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery 1981; 9: 672–8
   PubMed Web of Science ®Google Scholar
• Kostron H, Grunert V. Possibilities of improving the results of photodynamic therapy of malignant brain tumors. Lasers Med Sci 1987; 2(1)5
   Google Scholar
• Kostron H, Swartz M R, Martuza R L. Co-60 and direct intraneoplastic injection of HPD enhances the effect of phototherapy. J Neurooncol 1988, in press
   PubMed Web of Science ®Google Scholar
• McCulloch G A, Forbes I J, See K L, Cowled P A, Jacke F J, Ward A D. Phototherapy in malignant brain tumors. Porphyrin localisation and treatment of tumors, D R Doiron. Alan R. Liss, New York 1984; 709–17
   Google Scholar
• Kaye A H, Morstyn G, Brownbill D. Adjuvant high dose photoradiation therapy in the treatment of cerebral glioma: a phase I–II study. J Neurosurg 1987; 67: 500–5
   PubMed Web of Science ®Google Scholar
• Wise B L, Taxdal D R. Studies of the bloos-brain barrier using hematoporphyrin. Brain Res 1967; 4: 387–9
   PubMedGoogle Scholar
• Svaasand L O. Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors. Porphyrin localisation and treatment of tumors, D R Doiron, C J Gomer. Alan R. Liss, New York 1984
   Google Scholar
• Kostron H, Swartz M R, Miller D C, Martuza R L. The interaction of hematoporphyrin derivative, light and ionizing radiation in a rat glioma model. Cancer 1986; 57: 964–70
   PubMed Web of Science ®Google Scholar
• Kostron H, Bellnier D A, Lin Ch W, Swartz M R, Martuza R L. Increased levels of hematoporphyrin derivative in a rat glioma following direct intraneoplastic injection. J Neurosurg 1986; 64: 868–74
   Web of Science ®Google Scholar
• Lam S, Kostashuk E C, Coy E P, Laukkanen E, Le Riche I C, Mueller H A, Szasz I J. A randomized comparative study of the safety and efficiency of photodynamic therapy using photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small cell bronchogenic carcinoma. Photochem Photo-biol 1987; 46: 893–8
   PubMed Web of Science ®Google Scholar
• Tator C H, Wassenaar W. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy. Neurosurg 1977; 46: 165–74
   Web of Science ®Google Scholar
• Ostertag Ch. Interstitielle stereotaktische Radiothera-pie von Hirntumoren. Wien Klin Wochenschr 1987; 11: 380–4
   Google Scholar
• McCulloch G A. Long term follow up of a phase I study of hematoporphyrin derivative in patients with malignant brain tumours. Lasers Med Sci 1987; 2(1)7
   Google Scholar
• Rounds D E, Jaques S, Shelden Ch, Shaller C A, Olson R S. Development of a protocol for photoradiation therapy of malignant brain tumors. Part I: photosensi-tisation of normal brain tissue with hematoporphyrin derivative. Neurosurgery 1982; 11: 500–5
   PubMed Web of Science ®Google Scholar
• Wharen R E, Jr, Anderson R E, Laws E R, Jr. Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues. Neurosurgery 1983; 12: 446–50
   PubMed Web of Science ®Google Scholar
• Waldow S M, Dougherty T J. Interaction of hyperthermia and photoradiation therapy. Radiation Res 1984; 97: 380–5
   PubMed Web of Science ®Google Scholar
• Loeken M K. The effects of roentgen rays on several biological systems with special reference to their modification by hematoporphyrin. PhD Thesis, University of Minnesota. 1956
   Google Scholar
• Bellnier D A. In vitro photoradiation–hematoporphyrin derivative accumulation, sensitization and interaction with ionizing radiation. PhD Thesis, University of Buffalo. 1982
   Google Scholar
• Cheng M K, McKean J, Boisvert D, Tulip J. Photoradiation therapy: current status and applications in the treatment of brain tumors. Surg Neurol 1986; 25: 423–35
   PubMedGoogle Scholar
• Salcman M F. Survival in glioblastoma: histological perspective. Neurosurgery 1980; 7: 435–9
   PubMed Web of Science ®Google Scholar
• European Organisation for Research and Treatment of Cancer (EORTC) Brain tumor group. evaluation of CCNU, VM-26 plus CCNU and procarbazine in supratentorial gliomas. Final evaluation of a randomized study. J Neurosurg 1981; 55: 27–31
   PubMed Web of Science ®Google Scholar
• Walker M D, Green S B, Byar D P. Randomized comparisons of radiotherapy and nitroureas for the treatment of malignant gliomas after surgery. New Engl J Med 1980; 303: 1323–9
   PubMed Web of Science ®Google Scholar
• Forbes I J, Cowled P A, Mackenziel L, Bronsbury S L. Improving the efficacy of photodynamic therapy with hematoporphyrin derivative. Lasers Med Sci 1987; 2(0)3
   Google Scholar
• Ben-Hur E, Green M, Prager A, Kol R, Rosenthal I. Phthalocyanine photosensitization of mammalian cells: biochemical and ultrastructural effects. Photochem Photobiol 1987; 46: 651–6
   PubMed Web of Science ®Google Scholar
• Spikes J D. Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol 1986; 43: 691–9
   PubMed Web of Science ®Google Scholar